Form 4: CompoSecure Chief Revenue Officer Amanda Gourbault Reports Stock Sales
SEC Form 4
Amanda Gourbault, Chief Revenue Officer of CompoSecure, Inc., reported the sale of Class A Common Stock in multiple transactions between February 25 and February 27, 2025.
Summary
- Amanda Gourbault, the Chief Revenue Officer of CompoSecure, Inc. (CMPO), filed a Form 4 detailing changes in beneficial ownership.
- On February 25, 2025, she sold 900 shares of Class A Common Stock at $16 per share.
- On February 26, 2025, she sold 100 shares of Class A Common Stock at $16 per share.
- On February 27, 2025, she sold 9,622 shares of Class A Common Stock at a weighted average price of $16.09.
- Following these transactions, Gourbault beneficially owns 821,782 shares of Class A Common Stock.
- This total includes directly owned shares, shares purchsed under the Employee Stock Purchase Plan, and shares underlying restricted stock units (RSUs) that will vest at various dates in the future.
- Some RSUs are performance-based and will vest based on the achievement of performance targets.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment, but the market may interpret insider sales in various ways.
Future Outlook
The document does not contain explicit forward-looking statements, but it does mention future vesting dates for RSUs, which are contingent on continued service and, in some cases, the achievement of performance targets.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. These filings are closely watched by investors as they can provide insights into management's perspective on the company's stock and future prospects. However, sales do not necessarily indicate a negative outlook, as they can be driven by personal financial planning needs.
Comparison to Industry Standards
- It's common for executives at publicly traded companies to have compensation packages that include stock options and restricted stock units (RSUs).
- The vesting schedules and performance-based vesting criteria are typical components designed to align executive incentives with shareholder value creation.
- Comparing Gourbault's transactions to those of executives at similar companies in the financial technology or secure payment solutions industry would provide a more detailed benchmark.
- Companies like Thales, Gemalto (now part of Thales), and IDEMIA are comparible companies in the secure payment solutions industry.
Stakeholder Impact
- The stock sales by a key executive could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding shares.
- Employees holding company stock or RSUs may also be sensitive to insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Sale of 900 shares of Class A Common Stock at $16 per share. |
| 02/26/2025 | Sale of 100 shares of Class A Common Stock at $16 per share. |
| 02/27/2025 | Sale of 9,622 shares of Class A Common Stock at a weighted average price of $16.09 per share; Form 4 filing date. |
| 01/01/2026 | Vesting date for 75,000 shares of Class A Common Stock underlying RSUs. |
| 01/01/2026 | Vesting date for 43,658 shares of Class A Common Stock underlying RSUs. |
| 01/01/2026 | First vesting date for 107,129 shares of Class A Common Stock underlying RSUs (vesting ratably). |
| 01/01/2027 | Second vesting date for 107,129 shares of Class A Common Stock underlying RSUs (vesting ratably). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.